|
IntelligentMDx to Provide Analytical and Verification Services to a Major Academic Institution
IntelligentMDx has agreed to provide services to a major academic institution related to sequencing confirmation of the 16S ribosomal RNA gene. In addition to DNA sequencing, IntelligentMDx will use its unique proprietary bioinformatics processes to provide analysis and verification of the initial sequencing results obtained by the institution for the identification of various microorganisms.
Financial terms of the sale have not been released.
About IntelligentMDx
IntelligentMDx’s mission is to make FDA approved diagnostic kits. To guarantee quality for customers and partners, we design, develop and manufacture tests under FDA Quality System Regulations and ISO 13485:2003 guidelines. These tests have been, and will be, designed to run on a broad range of molecular systems for clinical diagnostics, drug development and applied sciences.
IntelligentMDx designs, develops and commercializes clinically impactful molecular diagnostic tests. Our goal is to support clinicians in their efforts to provide care with certainty. Our commercial offerings include emerging and re-emerging infectious threats and are available for use in CLIA laboratories covering the rapidly growing markets for transplant and health care-associated infections. IntelligentMDx’s expertise spans evolutionary biology, bioinformatics, and wet lab/molecular biology capabilities, harnessed by our proprietary product development process allowing for the rapid design and development of tests to meet clinical needs.
Media Contact:
For more information on IntelligentMDx, visit www.IntelligentMDx.com or contact Corporate Communications at cc@IntelligentMDx.com, 617-871-6400.
|